Latest Investment News

Nanosonics delivered a robust FY25 with 17% revenue growth and a 72% jump in profit before tax, propelled by next-gen trophon devices and advancing CORIS commercialisation.

Viva Energy reported a statutory half-year loss of $195.4 million driven by significant retail site impairments and weak refining margins, yet underlying profit on a replacement cost basis remained positive at $62.6 million. The company declared a fully franked interim dividend of 2.83 cents per share, signaling confidence despite operational headwinds.

IVE Group Limited reported a 69% jump in net profit for FY25 despite a slight revenue dip, driven by margin expansion and operational efficiencies. The company maintains a strong balance sheet and outlines ambitious growth and sustainability plans for FY26.

Felix Group Holdings Ltd has launched a capped $1 million Share Purchase Plan (SPP) offering eligible shareholders a discounted entry to support its strategic acquisition of Nexvia Pty Ltd and fuel growth initiatives. This retail-focused SPP complements a larger institutional placement as Felix aims to expand its enterprise software footprint.

Marimaca Copper Corp. has released a Definitive Feasibility Study for its Marimaca Oxide Deposit in Chile, highlighting a robust 13-year mine life, low capital intensity, and strong financial returns. The study confirms a maiden ore reserve and positions the project as a competitive copper producer with advanced permitting and financing underway.

Tribeca Global Natural Resources Limited has reversed last year’s loss to report a $5 million profit and declared a fully franked dividend, while unveiling a significant share buyback program to address its discount to net tangible assets.

Australian Clinical Labs delivered solid FY25 financial results with revenue up 6.4% and EBIT rising 8.7%, underpinned by operational efficiencies and strategic innovation. The company’s FY26 guidance signals continued growth amid evolving market conditions and government fee pressures.

Australian Clinical Labs reported robust FY25 financial results with revenue and earnings growth, alongside a strong dividend payout and positive outlook for FY26.

Australian Clinical Labs reported a 6.4% revenue increase and an 8.7% rise in underlying EBIT for FY25, maintaining disciplined growth and operational efficiency in a complex healthcare environment.

Felix Group Holdings has launched a $1 million Share Purchase Plan offering shares at a 3.7% discount to support its acquisition of Nexvia Pty Ltd and growth initiatives.

Fortescue Metals Group reported a solid US$3.4 billion net profit for FY25, driven by record iron ore shipments and a strong balance sheet, while advancing ambitious decarbonisation and green energy projects.

WebBeds reported a 22% rise in Total Transaction Value to nearly $5 billion for FY25, while EBITDA fell 14% amid margin pressures and higher costs. The company is targeting $10 billion TTV by FY30 with improved profitability.